This review concluded that patients without myelopathy had a high chance of remaining progression free at follow-up whereas patients with myelopathy may have benefited from surgery due to high rate of progression. The reliability of the conclusions is uncertain due to lack of quality assessment, variation in studies and one study contributing most of the data to the analysis.
Study selection
Studies which included ossification of the posterior longitudinal ligament patients, who were conservatively managed without surgical intervention and that reported the progression of myelopathy after clinical follow-up were eligible for inclusion. The outcome of interest was change in clinical progression of myelopathy after follow-up.
The included studies reported the following conservative management: clinical follow-up; bed rest; neck immobilisation; cervical brace with mandibular support; decreased activity levels; in-patient traction; short duration of dexamethasone treatment; neck brace; and rehabilitation. Most of the patients presented without any signs of myelopathy. Reasons for non-surgical intervention varied between studies. Some studies used Japanese Orthopaedic Association scores to evaluate the severity of myelopathy (highest score was 17 points).
Three reviewers independently selected studies for inclusion.
Assessment of study quality
The authors did not state that they assessed validity.
Data extraction
Data were extracted for the number of patients conservatively managed (%), mean duration of follow-up and radiological change on follow-up. Mean Japanese Orthopaedic Association scores were extracted if available.
Three reviewers independently performed the data extraction; disagreements were resolved through consensus.
Methods of synthesis
The studies were combined in a narrative synthesis and presented as the proportion of patients with and without myelopathy at initial presentation and after clinical follow-up.
